![](/img/cover-not-exists.png)
Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer
Mouri, Atsuto, Kaira, Kyoichi, Yamaguchi, Ou, Shiono, Ayako, Miura, Yu, Hashimoto, Kosuke, Nishihara, Fuyumi, Murayama, Yoshitake, Kobayashi, Kunihiko, Kagamu, HiroshiLanguage:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-019-03926-y
Date:
August, 2019
File:
PDF, 758 KB
english, 2019